Defective interfering 
Defective, homologous, autointerfering viral particles containing subgenomic RNA or DNA fragments instead of an entire viral genome have been described for nearly all classes of animal virus (1-7) since they were first observed by von Magnus (8) with influenza virus. In all cases, these defective interfering particles arise after repeated passages of virus at high multiplicity of infection, and the maintenance of these defective viruses requires coinfection of cells with standard infectious virus to support their replication.
It was recognized several decades ago (9) that interfering viral particles may have potential for prophylaxis against virus disease. von Magnus in 1951 (10) and Bernkopf in 1950 (11) showed that defective influenza virus particles provided slight protection of mice against very low doses of infectious influenza virus, but these results were complicated by the fact that purified defective virus preparations were not available. Definitive studies of the prophylactic potential of T particles have not been performed with any virus. Huang and Baltimore suggested recently (12) that defective interfering virus particles may play a significant role in viral disease in vivo. Although there are several animal virus infections in which defective virus particles seem to be important [e.g., lymphocytic choriomeningitis virus (13) and arbovirus infections (14) ], in vivo effects of defective interfering particles remain obscure. Vesicular stomatitis virus (VSV) offers several advantages for the study of in vivo effects of defective viruses. Its regular, bullet shape allows sucrose velocity sedimentation to be used for separation of the shorter, defective T particles from standard length, infectious virions (15) . Furthermore, the physical and biological characteristics of the defective T particles of VSV have been studied extensively in vitro. T particles of VSV contain virion proteins identical to those of infectious virions (16); they lack the transcriptase activity of infectious virus and seem not to express their genetic information; they apparently interfere with infectious virus by competition for replication of RNA rather than transcription or translation (17) (18) (19) (20) (21) . We have reported (22) 37 ,000 rpm in a Spinco SW41 rotor. The top two-thirds of the well-separated T-particle band was carefully aspirated with a pasteur pipette from all tubes and pooled (15-30 mg average total T-particle yield). T particles were diluted in MEM, concentrated by sedimentation onto 0.2-ml glycerol cushions in an SW41 rotor, resuspended in TEN buffer-1% *--*, six mice were each inoculated intracerebrally with 250 PFU of infectious virus alone. Two mice were killed on day 1, two mice died on day 2, and two mice died on day 3. The brain of each mouse was homogenized in MEM and plaque-assayed on BHK21 cell monolayers. X X, 23 mice were each inoculated intracerebrally with a mixture of 250 PFU of infectious virus plus 5 X 1010 T particles. Individual mice were killed on the indicated days for plaque assay of infectious virus in the brain, and each X indicates the virus titer in each mouse brain. Points just above the abscissa denote mice with no detectable virus (less than 10 PFU per brain). B and T particles were Indiana serotype. We finally used a technique by which concentrated Tparticle suspensions could consistently be prepared completely free of infectious virus. This method, described above, requires four consecutive rate zonal centrifugation steps in sucrose gradients and great care to avoid virus contamination, since more than a 109-fold purification of T particles from infectious virus is required. Preliminary in vitro biological characterization of these pure T-particle preparations is reported in the last section of this report.
Prophylactic effects of purified T particles Table 1 shows that highly purified T-particle preparations provided excellent protection of mice when injected intracerebrally along with low but lethal doses of infectious virus, and that they significantly prolonged survival times even with very large doses of homologous virus. Note that with the lowest dose of virus alone, nearly all control mice died within several days and nearly all mice receiving the same amounts of virus along with T particles survived indefinitely. When these survivors were challenged intracerebrally several weeks later with large doses of infectious virus alone they were found to be solidly immune (data not shown).
Note also in Table 1 that purified T particles showed decreasing protective capacity as the dose of virus was increased from 100 PFU to 106 PFU. At the higher doses nearly all mice eventually died, but the presence of T particles converted an otherwise rapidly fatal disease into a slowly progressing disease in which the animals showed progressive paralysis and generalized deterioration for many days before death. Fig. 1 compares the growth of virus in the brains of control mice given 250 PFU of infectious virus alone and of mice given the same dose of virus along with T particles. It can be seen that there was rapid growth of virus in the brains of control mice until their death at 2 or 3 days, but in the mice treated with T particles there was strong, early suppression of virus production. The brains of treated mice contained either no detectable virus or very little virus during the first days after infection. Over the next week, about half the mice showed increasing virus titers and half showed little or no virus. After 2 weeks no virus was detectable in any mice. It appears that T-particle interference suppresses virus production very strongly in most mice, and that it delays the produc-tion of significant amounts of virus in the brains of other mice until immunologic reactivity develops.
Specificity of T-particle interference in mice
In contrast to the data of Table 1 showing homologous protection, the data in Table 2 show that purified T particles from the Indiana strain of VSV did not provide heterologous protection against challenge with New Jersey serotype VSV nor against challenge with influenza virus. This result indicates that the in vivo protection is true homologous autointerference and is not due to interferon, VSV-receptor saturation, or other nonspecific effects. Interferon assays on the brains of mice injected with T particles alone or with T particles plus infectious virus showed the presence of little or no interferon.
Immunization with highly purified T particles Table 3 shows that virus-free T particles caused no apparent ill effects and no deaths when injected intracerebrally. Since T particles contain the same virion proteins as infectious virus (16), they might be expected to immunize at least as well as inactivated virions. Table 3 shows that in fact they do stimulate strong immunity. Within 10 days after intracerebral injection of virus-free T particle of Indiana serotype, mice developed immunity to challenge by large doses of infectious homologous virus, but they developed no immunity against the unrelated influenza virus.
Cytotoxicity and biochemical effects of virus-free T particles on BHK21 hamster cells in culture Huang et al. (15) , using partially purified T particles contaminated with low multiplicities of infectious virus, observed that T particles shut off host-cell RNA synthesis and caused cytopathic effects. Fig. 2 confirms that extremely high multiplicities (106/cell) of virus-free T particles depress BHK21 cell protein and RNA synthesis, and they kill the majority of cells within 24 hr. No infectious virus could be recovered from the dying cells, as detected by plaque assay or by further passage of virus dilutions in BHK21 cells. After the few surviving cells were washed and refed, they multiplied to give virus-free but fully virus-susceptible cultures within 8 days.
Lower, but still very high, multiplicities of purified T particles (105 T particles per cell) did not significantly depress cellular synthesis or damage most cells. Nevertheless, these 10-fold lower multiplicities of T particle caused over 99% interference with virus production. Since T particles do not appear to express the genetic information of their genome fragments (17) (18) (19) (20) (21) , the cytotoxicity caused by massive multiplicities of T particles may be a result of membrane alterations after attachment and fusion (24) of many T particles, and probably does not require or reflect expression of a gene function.
DISCUSSION
Although these studies were confined to intracerebral inoculation rather than natural routes of infection, they do suggest that virus-free, defective interfering particles could offer considerable prophylactic and immunizing potential against animal and human viral disease wherever they can be purified free of all infectious virus. At present, only other rhabdoviruses such as rabies virus appear to offer practical possibilities for total removal of infectious virus from large quantities of defective virus. If methods could be devised for large-scale preparation of virus-free defective interfering particles from viral isolates during influenza virus pandemics or Newcastle disease epidemics in fowl, they might offer a definite prophylactic-immunizing potential not available in conventional vaccines. The poor protective effects of defective VSV particles observed in our previous study (22) , in Mims' work with arbovirus (14) and in the earliest studies with influenza virus (10, 11) were undoubtedly due partly to the presence of harmful titers of infectious virus contaminating the defective particle preparations.
Our observation of slowly progressing virus disease in mice treated with T particles given higher doses of infectious virus reinforces the possibility raised by Huang and Baltimore (12) that defective interfering particles may play a role in the pathogenesis of some slow virus diseases. It also demonstrates the necessity for caution and for careful testing over wide dosages of virus before use of defective particles for prophylaxis and immunization of domestic animals and humans.
